Iron (Fe) is the most abundant redox-active metal ion in the human body, and its redox-active inter-convertible multiple oxidation states contributes to numerous essential biological processes. Moreover, iron overload can potentially cause cellular damage and death, as wel as numerous diseases through the aberrant production of highly reactive oxidative species (hROS). Protein-free or weakly-protein-bound Fe ions play a pivotal role as catalytic reactants of the Fenton reaction. In this reaction, hROS, such as hydroxyl radicals and high valent-ironoxo species, are generated by a reaction between hydrogen peroxide and Fe(II), which is re-generated through reduction using abundant intracellular reductants, such as glutathione. This results in the catalytic evolution of hROS. Thus, selective detection of the catalytic Fe(II) in the living systems can explain both of the pathological and physiological functions of Fe(II). Written from the perspective of their modes of actions, this paper presents recent advances in the development of fluorescent and bioluminescent probes that can selectively detect catalytic Fe(II) together with their biological applications.
Introduction
Iron is a redox-active biological metal ion, and is the most abundant transition metal species in the human body. Over 60% of the total iron exists in red blood cells, as an active center of hemoglobin, which transports oxygen throughout the body [1] [2] [3] [4] . Majority of the remaining iron either exists in the form of ferritin, which is an iron-storage protein, or in the active centers of redox-relevant enzymes, such as cytochrome P450, mitochondrial complexes, and ribonucleotide reductase [5] . Biological systems control redox activity of iron by appropriately placing the metal species inside certain proteins that act as protective groups against undesired redox processes and also as chemical spaces for the enzymatic reactions. In contrast, only less than 1% of iron species, known as labile iron species, exist without coordination by the specific proteins as ligands during the dynamic equilibrium of intracellular iron homeostasis ( Fig. 1) [4, 6] . Although the redox activity of iron enables incredible enzymatic reactions such as C-H functionalization [1] , its high reactivity also poses potential danger, such as aberrant production of highly reactive oxygen species (hROS) including hydroxyl radical via Fenton chemistry when iron levels exceed the cellular anti-oxidative capacity [5, 7] . Thus, the homeostasis of iron both in cells and the whole body is tightly controlled to maintain the iron levels. In fact, several serious diseases including cancers [7] [8] [9] , neurodegenerative diseases [9] [10] [11] , hepatitis [12] , and mesothelioma [13] have been shown to be relevant to excessive accumulation of iron species concomitantly with oxidative stress. Although iron has exchangeable multiple redox states (Fe(II) and Fe(III)) or transiently higher redox states, factors such as reductive intracellular environment, difference in water solubility, and iron transporters allow the subcellular iron species to exist as Fe(II) rather than Fe(III) (Fig. 1) [14] . The cellular iron uptake machinery primarily utilizes a divalent metal transporter 1 (DMT1) and ferroportin (FPN) as the importer and exporter of iron because Fe(II) is recognized as their substrates [15, 16] . The cytosolic and mitochondrial iron chaperones (PCBP1/2 and Frataxin, respectively) also selectively recognize Fe(II) [17] [18] [19] . These facts suggest that the Fe(II) species predominantly mediates the intracellular dynamic equilibrium of iron through the delivery and transport as Fe(II) form. In addition, Fenton chemistry is triggered by a reaction between Fe(II) and hydrogen peroxide to generate hydroxyl radicals and high-valent iron-oxo species, which damage DNA, proteins, and lipids ( Fig. 1) [20] [21] [22] [23] . The Fenton process proceeds in an Fe(II)-catalyzed manner because the abundant subcellular reductant, i.e. glutathione, regenerate Fe(II). In this regard, this review refers to important terms: labile Fe(II) and catalytic Fe(II), which are defined differently here. Labile Fe(II) indicates endogenously existing Fe(II) species that are relevant to physiological processes such as iron uptake while catalytic Fe(II) refers to Fe(II) species that are involved in oxidative stress.
Selective detection methods of intracellular iron species in the form of its labile and catalytic Fe(II) have been in high demand owing to the importance of Fe(II) in oxidative stress as catalytic Fe(II) [24] . Fluorescence imaging is one of the most powerful methods to monitor biological processes, especially to detect short lifetime species such as catalytic Fe(II) in living cells. A significant amount of research has been devoted to monitoring "chelatable iron species" with conventionally available chelation-based fluorescent probes, including Calcein and PhenGreen-SK (Fig. 2) [6, [25] [26] [27] . Although these probes have significantly contributed to establishing the concept of labile iron, they suffer from turn-off responses (Fig. 2a) and insufficient metal selectivity owing to the fluorescence quenching properties of Fe(II) and relatively weak binding properties among the first-row transition metal ions according to the Irving-Williams series. Other chelation-based fluorescent probes for Fe(II) with turn-off readout have been reviewed elsewhere [28, 29] . To overcome the problems of chelation-based strategy, several groups including ours developed new chemical probes for Fe(II) with turn-on readout and high selectivity concerning metal ion and redox state, based on classical but novel Fe(II)-selective chemical reactions [30] . This review summarizes recent progress in the development of fluorescent probes for Fe(II) and their properties and applications of imaging catalytic/labile Fe(II) species.
Chemical reaction-based fluorescent probes for Fe(II) with turnon response
Water solubility, cell-membrane permeability, and low toxicity are the minimum requirements that should be considered to design fluorescent probes for cellular imaging. Considering selectivity against a target is particularly important as various biological molecules including proteins, DNA, lipids, oxidants (reactive oxygen species, ROS), reductants, and metal cations, exist in an intracellular medium. As iron is one of the trace elements found in our body, a fluorescent probe must be highly selective with respect to Fe(II) ions over the other abundant biological molecules. Specific discrimination of Fe(II) from Fe(III) and other metal cations in a chelation strategy, which is employed for the conventional turn-off fluorescent probes, offers several challenges including turn-off readout, selectivity, and sensitivity, all of which originate from the intrinsic nature of Fe(II) as described above. Chemical reaction-based sensing is an alternative strategy, commonly employed for ROS detection, to address the abovementioned challenges. Such chemical reaction-based fluorescent probes provide their readout when chemically reacting with their target molecules. Thus, this design approach is preferable to overcome the disadvantages of chelation-based probes. Recent fluorescent probes that depict turn-on readout and high selectivity are categorized as chemical reaction-based probes that exploit the unique chemical reactivity of Fe(II) ( Table 1 ) [30] . Although the response modes of the reactivity-based fluorescent probes are irreversible, the selective turn-on detection mechanism facilitates an indepth discussion regarding biological and pathological functions of Fe (II) with an intracellular redox state, without abstracting Fe ions from natural metallo-proteins enabled. (Table 1) .
N-oxide-based fluorescent probes and their applications
Our group developed the first turn-on fluorescent probe selective to Fe(II), RhoNox-1, that utilizes Fe(II)-mediated deoxygenation of [38] [39] [40] [41] [42] [43] [44] [45] tertiary amine N-oxide for the selective detection of Fe(II) ( Fig. 3a and b) [32] . The deoxygenation reaction is preferably mediated by Fe(II) as it has a lower redox state than Fe(III); this is due to the reaction being formally reductive deoxygenation. RhoNox-1 displayed negligible fluorescence by itself (quantum yield = 0.01) because the N-oxide acts as a caging unit of fluorescence through multiple photophysical processes, including photo-induced electron transfer (PET), twisted intermolecular charge transfer (TICT), and breaking of the π-conjugation of the chromophore. The N-oxide unit of RhoNox-1 is readily cleaved upon reacting with Fe(II), resulting in the recovery of the parent fluorophore, rhodamine B, and a turn-on response up to 30-fold over 1 h (Fig. 3e ).
The response of RhoNox-1 is distinctly selective to Fe(II) over other biologically relevant transition metals such as Zn(II) (Fig. 1f) , reductants including glutathione and ascorbate, and ROS. The probe not only enhances fluorescence against exogenously added Fe(II) (100 µM) ( Fig. 3g ) but also decrease fluorescence in the presence of an Fe(II) chelator, 2,2′-bipyridyl (Bpy, 1 mM), indicating that the endogenous labile Fe(II) could be detected in live hepatocellular carcinoma (HepG2) cells using RhoNox-1 [32] .
Live cell imaging of catalytic Fe(II) using RhoNox-1 revealed the fluctuation of intracellular iron during light-induced damage of retina cells (661 W cells) as an aged macular disease model [40] ; elevation of intracellular catalytic Fe(II) in lung carcinoma (A549) cells incubated in the plasma-activated medium [41] ; distribution of Fe(II) in ovalbumininduced peritonitis [42] ; involvement of catalytic Fe(II) in the carbon nanotube-induced mesothelioma [43] ; and fluctuations of catalytic Fe (II) in other biologically or pathologically stimulated cells [44] [45] [46] [47] [48] . Furthermore, RhoNox-1 was successfully applied to the histochemical detection of the accumulation of catalytic Fe(II) in a frozen section of tissue that was prepared from rats treated with ferric (Fe(III)) nitrilotriacetate (Fe-NTA) as an excessive iron-induced carcinogenesis model (Fig. 3h ) in collaboration with Toyokuni et al. [49] . Intraperitoneal injection of Fe-NTA was assumed to generate Fenton reaction-active Fe (II) from Fe(III) via a glutathione-redox cycle because considerable oxidative damage of DNA that occurs via Fenton chemistry is a characteristic signature of ROS-induced carcinogenesis. The frozen sections of the proximal renal tubules prepared from Fe-NTA-treated rats exhibited significantly higher fluorescence signals than those of control rats when they were stained with RhoNox-1. Notably, our probe worked only in freshly prepared frozen sections but did not in paraffin-embedded sections because Fe(II) ions not bound to proteins are easily washed away from the tissue samples during the paraffin preparation process that usually requires multiple washings. Another example of RhoNox-1 application was to monitor the translocation of intracellular Fe(II) to lysosomes in salinomycin-induced death of cancer stem cells [50] . The abovementioned applications that are related to studying the dynamics and function of Fe(II) are relevant to oxidative stress, suggesting that the probe can detect catalytic Fe(II) that acts as a catalyst in Fenton chemistry.
Our group also presented a variant of RhoNox-1, HMRhoNox-M, that has improved turn-on contrast (60-fold) achieved by regulating the spirocyclization profile (Fig. 3c) [33] . This probe has successfully detected an increase in labile Fe(II) delivered by transferrin, non-thermal plasma-induced accumulation of catalytic Fe(II) in mesothelioma cells, and catalytic Fe(II) in ovarian endometriosis-associated stromal cells. [51, 52] Our recent research expanded the applicability of the N-oxide chemistry-based strategy to other fluorophores, including coumarin, rhodol, and silicon-incorporated rhodamine (SiRhodamine) to establish a color palette of fluorescent probes (Fig. 3d ) [34] . All the different colored fluorescent probes, CoNox-1, FluNox-1, and SiRhoNox-1, depict fluorescence enhancement (10-fold, 30-fold, and 60-fold, respectively) in the blue, green, and deep red color regions, respectively, in cuvette and in living cells (Fig. 3g) . The exclusive selectivity to Fe(II) indicates that the N-oxide strategy is potentially applicable to various fluorophores containing π-conjugation systems with dialkylarylamine. The red probe, SiRhoNox-1 provided a higher response in terms of on/off contrast and response rate than those of RhoNox-1 both in cuvette and live cells and thus was applied to monitor the intracellular fluctuation of redox balance of labile Fe species between Fe(II)/Fe(III) in response to oxygen concentrations (Fig. 3i) [53] . Thus, our recent study has established a new molecular switch that is highly specific to labile/catalytic Fe(II) together with a design strategy for Fe (II)-selective fluorescent probes.
Endoperoxide-based fluorescent probes and their applications
Endoperoxide is a cyclic structure containing a bridged O-O bound, and its unique reactivity, i.e., a reductive O-O bond break by Fe(II), is utilized as the action trigger for antimalarial drugs originating from artemisinin [54] . Although endoperoxide compounds are generally unstable in living cells owing to the susceptibility of O-O bonds to heat and biological reductants, Bogyo et al. overcame the instability of the endoperoxide compound by employing a bulky spirocyclic structure comprising 1,2,4-trioxolane and adamantyl group and successfully developed Fe(II)-cleavable prodrugs (Fig. 4a) [55] . Renslo and Wells et al. used this chemistry to detect labile Fe(II) through the development of Trx-puro, which is an Fe(II)-activatable puromycin. In this system, activity of puromycin in Trx-puro is caged by the adamantyl-1,2,4-trioxolane unit through a traceless linker (Fig. 4b) [35] . The caging unit is selectively cleaved via Fe(II)-promoted O-O bond break followed by a retro-Michael reaction, resulting in the intracellular release of the active form of puromycin, which can be quantified via a conventional immunostaining method using a puromycin antibody. Although the kinetics of the trioxolane strategy used in Trx-puro is not as high as that in the N-oxide chemistry, its high Fe(II) selectivity and compatibility to quantification via immunostaining enabled the comparison of labile Fe (II) levels between different cell lines. The Trx-puro-based method revealed that several cancer cell lines (RKO, MDA-MB-231, U-2 OS, and PC-3) hold significantly higher endogenous labile Fe(II) as compared with non-cancerous cell lines (IMR90 and MCF10A). Furthermore, this method was able to detect the decrease in the labile Fe(II) levels through the overexpression of ferritin or ferroportin, which are the major iron-storage proteins and iron exporters, respectively.
Subsequently, Chang et al. applied trioxolane chemistry to fluorescence detection of labile Fe(II). As depicted in the mechanism of Trxpuro action, the Fe(II)-mediated cleavage of the trioxolane unit provides two divided parts comprising cyclohexanone and a broken adamantyl moiety. In their study, FIP-1 was designed on the basis of this Fe (II)-triggered dissociation of the trioxolane core. FIP-1 has a pair of fluorescence resonance energy transfer (FRET) donor (fluorescein) and acceptor (Cy3) to each side of the trioxolane scaffold (Fig. 4c) [36] . Excitation of the donor results in red emission via FRET (from Cy5) before the reaction with Fe(II), whereas that of green (fluorescein) is enhanced upon the Fe(II)-promoted cleavage reaction. The FRET-type fluorescent probe, FIP-1, enables semi-quantification and comparison of labile Fe(II) between cell lines through self-calibration based on the ratio of the two fluorescence intensities that are derived from the donor and the acceptor. FIP-1 displayed a 1.7-fold ratio change over 1 h and excellent selectivity to Fe(II) in cuvette. The sensitivity of FIP-1 in cellulo is high enough to detect both exogenously supplied Fe(II) and the endogenous labile Fe(II) pool. The ratiometric readout facilitated the comparison of the endogenous labile Fe(II) state between MCF10a, MDA-MB-231, and U2OS cells, revealing higher labile Fe(II) that could be removed by deferoxamine (DFO) in the cancerous cell lines (MDA-MB-231 and U2OS) than that in the non-cancerous cell line (MCF10a). This result is consistent with the results of the in cellulo quantification using Trx-puro. Further, FIP-1 was applied to monitor the fluctuation of the catalytic Fe(II) during ferroptosis [56] , which is a novel type of iron-dependent cell death, resulting in significant elevation of catalytic Fe(II) in the MDA-MB-231 cells upon 35MEW28-induced ferroptosis (Fig. 4e) .
The endoperoxide-based molecular switch is potentially applicable to regulate photophysical properties of chromophores containing amine moiety as an electron donating group. Chang et al. expanded this chemistry to development of the bioluminescence probe, ICL-1, by caging the amino group of D-aminoluciferin with the trioxolane unit (Fig. 4d) [37] . ICL-1 provides negligible bioluminescence prior to the addition of Fe(II) in the presence of firefly luciferase, whereas incubating ICL-1 with luciferase in the presence of Fe(II) resulted in a dose-dependent increase in the luminescence signal. This result suggests that Fe(II)-triggered cleavage of the trioxolane-caging unit provides D-aminoluciferin as the substrate of luciferase. The probe also showed a detectable change in the luminescence signal in response to supplementation and depletion of Fe(II) in the living cells expressing firefly luciferase. As the bioluminescence imaging method is widely used for in vivo imaging, ICL-1 was also applicable to in vivo imaging of luciferase-expressing mice (FVB-luc + ). Through intraperitoneal (i.p.) injection of Fe(II) followed by injection of ICL-1, the mice with Fe(II)-treatment (20 mg/kg) displayed a higher bioluminescence signal than the control mice, whereas supplementation of Bpy (8 mg/kg), which causes depletion of Fe(II), resulted in a lower bioluminescence signal. Accumulation of catalytic Fe(II) brought by A. baumannii infection in living mice that was successfully monitored by ICL-1 bioluminescence imaging mice is presented in Fig. 4f . Bioluminescence Fe(II) imaging with ICL-1 together with laser ablation ICP-MS revealed that the infection with A. baumannii significantly elevated iron levels, especially in the liver. Because bioluminescence from the enzymatic reaction of firefly luciferase also requires adenosine triphosphate (ATP) together with luciferin as an energy source, the bioluminescence imaging results should be interpreted when considering the change in ATP levels, which was not significantly altered by the A. baumannii infection.
Cellular organelle-targeted fluorescent probes and their applications
Detection of local labile/catalytic Fe(II) in living cells is of great importance to fully understand the cellular homeostasis and its pathological alteration. We recently developed fluorescent probes that work at targeted organelles. Because of the small molecular size and easy installation property, our N-oxide strategy is suitable to build fluorescent probes bearing other functionalities including organelle-localizable chemical moiety. Two types of organelle-targeted fluorescent probes have been previously reported by our group. These include Mem-RhoNox and Ac-MtFluNox, which target the plasma membrane and mitochondrial matrix, respectively (Fig. 5) .
Mammalian cells have developed sophisticated machinery for iron uptake that can avoid oxidative damages stemming from the potential hazards associated with iron ions. Transferrin (Tf) and its receptor (TfR) contribute to the major cellular iron uptake process, Tf-mediated endocytosis [3, 5] . A Tf molecule holds two Fe(III) ions as an inactive Fe form and releases them inside the endosome. Although the released iron species has been considered as Fe(II) generated via intra-endosomal reduction due to the existence of DMT1 and ferrireductase (STEAP3) [57] , the redox state of the released iron is yet to be directly measured. Mem-RhoNox (Fig. 5a ) is designed to detect Fe(II) on the cell surface and to monitor intra-endosomal generation of labile Fe(II) species during Tf-mediated endocytosis (Fig. 5b ) [38] . This probe comprises a rhodamine N-oxide scaffold to detect Fe(II) bearing two palmitoyl arms as cellular membrane-anchoring domains; each of which is tethered through an aspartate and a tetraethyleneglycol linker. Thus, MemRhoNox can be retained on the cell surface with its Fe(II)-detection core exposed to extracellular medium, and then the surface-anchored probes can be internalized into Tf-triggered endosomes where the RhoNox-unit reacts with Fe(II) to cause fluorescence enhancement. We successfully applied Mem-RhoNox to real-time monitoring of labile Fe(II) release inside endosomes, demonstrating that Fe(II) was generated inside the endosomes in the Tf-mediated endocytosis (Fig. 5c) . Furthermore, the reduction of Fe(III) to Fe(II) on the cell surface prior to uptake was also visualized when Fe(III) was supplemented as an iron source. The Tf-mediated endocytosis is also the primary pathway of iron uptake for neuronal cells [58, 59] . Thus, MemRhoNox was used to visualize Tf-delivered Fe(II) in the primary cultured neurons. The results indicated that the probe was able to detect labile Fe(II) ions during the Tf-mediated endocytosis.
Mitochondria are iron-abundant organelles in cells owing to its requirement of iron in the energy production process and heme synthesis [2, 60] . ATP synthesis proceeds through a cascade of an electrontransporting chain that involves complexes I, II, III, and IV, all of which contain iron species. Both, the first and final steps of heme biosynthesis, i.e., synthesis of aminolevulinic acid and insertion of Fe(II) into protoporphyrin IX (PPIX), proceed in the mitochondria [61] [62] [63] [64] . This suggests that labile Fe(II) species should exist as the substrate of ferrochelatase, which inserts Fe(II) but not Fe(III) into PPIX [65] . Although Petrat et al. reported a careful estimation of the intramitochondrial concentration of labile iron using an imaging-based analysis with chelation-based probes, direct detection of the alteration of endogenous labile/catalytic Fe(II) in a mitochondria-specific manner has remained challenging. We developed MtFluNox and its cell-compatible analogue, Ac-MtFluNox, as turn-on fluorescent probes for mitochondrial labile Fe(II) (Fig. 5d) . The probe comprises a rhodol Noxide scaffold bearing triphenylphosphonium cation, which is widely used as a selective carrier to mitochondria. The acetyl group of AcMtFluNox is cleaved intracellularly via esterase-dependent hydrolysis to generate the active form, MtFluNox, which is readily delivered to mitochondria and exhibits its function. MtFluNox depicted unexpectedly fast response kinetics (2. for RhoNox-1) and high off/on contrast (100-fold), which is the best performance ever observed for the other N-oxide based probes. The imaging study with Ac-MtFluNox demonstrated mitochondria-specific enhancement of fluorescence signals in Fe(II)-treated HepG2 cells as compared with the control (Fig. 5e ). The staining pattern was highly overlapped with MitoTracker ® DeepRed, a commercially available mitochondria marker. Furthermore, the probe was successfully applied to monitoring of the alteration of endogenous mitochondrial labile Fe(II) via inhibition of the heme synthesis. Nitric oxide (NO) is known as an inhibitor of ferrochelatase [66, 67] , and thus the treatment of HEK293 cells with NOC-5, an NO generating reagent, enhanced the fluorescence signal derived from MtFluNox, which was cancelled in the presence of DFO. This demonstrates that Ac-MtFluNox could detect an accumulation of labile Fe (II) in mitochondria via the inhibition of heme synthesis. Notably, the imaging results acquired by Ac-MtFluNox should be considered with the mitochondrial membrane potential because the targeting mechanism depends on the negativity of the mitochondria matrix. Depolarization and hyperpolarization may cause leaking or overload of the probe, respectively, resulting in a misinterpretation of the imaging results. To avoid such misinterpretations, imaging experiments using the fluorescence counterpart of Ac-MtFluNox, AcMtRhodol, would be helpful to validate mitochondrial status.
Conclusions
Iron is not only a physiologically essential element, but also has pathological implications due to its redox activity. Majority of the intracellular iron pool exists in the form of Fe(II) species that weakly or does not bind to metalloproteins and catalytically generates hROS. This has motivated researchers to develop Fe(II)-selective fluorescent probes that work in living biological systems. In contrast to Zn(II) and Cu(I), the new class of the fluorescent probes enabling redox state-selective and turn-on/ratiometric detection of Fe(II) has only appeared in the last 5 years, suggesting that the study of imaging labile/catalytic Fe(II) may be in its early phase. The recent fluorescent probes reviewed in this article have produced numerous new insights to physiological cellular iron homeostasis and its alterations induced by hypoxia, inhibition of heme synthesis, ferroptosis, light irradiation, exposure to plasma-activated medium, and the A. baumannii infection and so on. The applicability of the probes is now being expanded to other fields owing to the universal importance of iron for all living organisms.
A few chemical switching units have recently emerged as general strategies for Fe(II) detection based on Fe(II)-dependent chemical reactions. It is important to note that users of the fluorescent probes must understand the properties and drawbacks of these probes, including subcellular localization, irreversible response, and difference of uptake/ leakage levels between cell lines. Together with other biologically essential chemical species such as ROS, reactive sulfur species (RSS), and small organic molecules, further efforts to develop novel probes for labile/catalytic Fe(II) will contribute to fully understanding the cellular redox signaling network and its dysfunction as pathogenesis factors where catalytic Fe(II) species play pivotal roles.
